Vimarsana
Biggest News Aggregation in the World

Emylee Thai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emylee Thai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emylee Thai Today - Breaking & Trending Today

Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California - Vimarsana News

Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California

/PRNewswire/ -- Artemis DNA, Inc. ("Artemis DNA" or the "company"), a leading global diagnostic laboratory company, announced today that they have made the...

Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California - Vimarsana News

Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California

/PRNewswire/ -- Artemis DNA, Inc. ("Artemis DNA" or the "company"), a leading global diagnostic laboratory company, announced today that they have made the...

Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California - Vimarsana News

Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California

The closure of the Texas location comes as the company begins a strategic transformation to focus on their business operations and expand their oncology portfolio and testing services in California.

Datar cancer genetics announces foray into the United States with a $250m contract to offer pioneering cancer detection liquid biopsies - Vimarsana News

Datar cancer genetics announces foray into the United States with a $250m contract to offer pioneering cancer detection liquid biopsies

Datar Cancer Genetics (Datar), a world-leading cancer research corporation today announced a USD 250 million contract with Artemis DNA, a leading USA-based di

DATAR CANCER GENETICS ANNOUNCES FORAY INTO THE UNITED STATES WITH A $250M CONTRACT TO OFFER PIONEERING CANCER DETECTION LIQUID BIOPSIES - Vimarsana News

DATAR CANCER GENETICS ANNOUNCES FORAY INTO THE UNITED STATES WITH A $250M CONTRACT TO OFFER PIONEERING CANCER DETECTION LIQUID BIOPSIES

LONDON, May 9, 2022 /PRNewswire/ -- Datar Cancer Genetics ('Datar'), a world-leading cancer research corporation today announced a $250 million